|Cytosorbents Corp., of Monmouth Junction, N.J.||Cytosorb||Blood purification technology||Treats cytokine storm and deadly inflammation in critically-ill and cardiac surgery patients||Has been approved to be marketed and sold in Mexico by the country's health authority, COFEPRIS|
|Enlightenvue Inc., of Denver||Surgivue||Two millimeter, single-use microendoscope system||For the visualization of body cavities, hollow organs, and canals||Received 510(k) marketing clearance from the U.S. FDA|
|Qiagen NV, of Hilden, Germany||Qiastat-Dx Respiratory SARS-CoV-2 panel||Syndromic testing solution; delivers results in about 1 hour||For use in diagnosing patients infected with COVID-19; can differentiate the SARS-CoV-2 coronavirus from 21 other serious respiratory infections||Received emergency use authorization from the U.S. FDA|
|Siemens Healthineers AG, of Erlangen, Germany||Rapidpoint 500e Blood Gas system||Analyzer that generates blood gas, electrolyte, metabolite, CO-oximetry, and neonatal bilirubin results||For diagnosing and monitoring critically ill patients in the intensive care unit, operating room or emergency room||Received 510(k) marketing clearance from the U.S. FDA|
For more information about individual companies and/or products, see Cortellis.